-
Product Insights
Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2016" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H2, 2016" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Syphilis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Syphilis Global Clinical Trials Review, H2, 2016" provides an overview of Syphilis clinical trials scenario. This report provides top line data relating to the clinical trials on Syphilis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H2, 2016" provides an overview of Genital Warts (Condylomata Acuminata) clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Warts (Condylomata Acuminata). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Filariasis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Filariasis Global Clinical Trials Review, H2, 2016" provides an overview of Filariasis clinical trials scenario. This report provides top line data relating to the clinical trials on Filariasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Genital Herpes Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H2, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cellulitis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Cellulitis Global Clinical Trials Review, H2, 2016" provides an overview of Cellulitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Hepatitis B Virus (HBV) Therapeutics – Current and Future Players
GlobalData has released its pharma report, “Hepatitis B Virus (HBV) Therapeutics - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HBV Market. The report identifies and analyses the key companies shaping and driving the global HBV market. The report provides insight into the competitive HBV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary...
-
Sector Analysis
Hepatitis B Virus (HBV) Therapeutics – US Drug Forecast and Market Analysis to 2024
Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths...
-
Sector Analysis
Hepatitis B Virus (HBV) Therapeutics – Japan Drug Forecast and Market Analysis to 2024
Chronic hepatitis B virus (HBV) infection is a serious chronic liver disease caused by the failure of viral clearance following acute HBV infection. Despite the availability of effective prophylactic vaccines, the disease remains a serious global health concern, with estimated over 350 million people worldwide currently living with this condition. In addition, patients with chronic hepatitis B are at a high risk of developing life-threatening complications including liver cirrhosis and hepatocellular carcinoma (HCC). In 2010, an estimated 786,000 HBV-related deaths...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.